atepeq/tico19 huggingface dataset:
Herein lie the secrets of why asymptomatic carriers are seen and what causes the severe cases in human infection.
Iccitiin waa’ee baattota dhukkubaa mallattoo maleeyyii fi maaltu dhala namaatti dhukkuba hammeessa jedhu soba.
The severe symptoms are mainly due to the hyperactivation of immune response and the cytokine storm wherein the stronger the immune response, the more severe the lung damage.
Mallattoowwan dhukkubaa cimoon adda durummaan hyperactivation dandeettii ittisa qaamaa fi saayitookaayinii dandeettii ittisa qaamaa cimaa, somba haala ulfaataa ta’een huba.
In contrast, in asymptomatic carriers, the immune response has been de-coupled from CoV replication.
Faallaa kanaa, baattoonni mallattoo hin qabne deebiin madiinummaa walhoruu CoV irraa adda bahe.
The same strategy of delinking the immune response might have beneficial effects in anti-SARS-CoV-2 therapy.
Tarsiimoo wal fakkaataa dandeettii ittisa qaamaa adda baasuun yaala -SARS-CoV-2’f bu’aa gaarii qabaachuu mala.
The interferon response is particularly strong in bats.
Deebiin Interfiiroon kan simbirootaa halkanii addatti cimaadha.
Thus, administration of type I interferon at least in the early phase of SARS-CoV-2 infection in humans should be beneficial.
Kanaafuu, haggansi intarfiiraan gosa tokkoffaa yoo xiqqaate sadarkaa jalqabaa faalama SARS-CoV-2 nama keessatti fayyadamaa ta’uu qaba.
In addition, NLRP3 inflammasome activation in bats is defective.
Dabalataan, NLRP3 inflammasome activation kan jedhamu simbira halkanii keessatti hanquudha.
By this reasoning, inhibition of NLRP3 inflammasome with MCC950 might be useful in the treatment of COVID-19.
Sababoota kanaan, NLRP3 MCC950’n dhoksuun yaala COVID-19’tiif faayidaa qabaachuu danda’a.
The emergence of SARS-CoV-2 follows the general theme by which SARS-CoV and MERS-CoV arose.
Argamni SARS-CoV-2 yaada waliigalaa dagaagina SARS-CoV fi MERS-CoV hordofsiise.
Whereas a bat beta-CoV sharing 95% nucleotide homology with SARS-CoV has been found, there also exists a bat-CoV sharing 96% nucleotide homology with SARS-CoV-2.
beta-CoV’n simbira halkanii SARS-CoV wajjiin niwuukilootaayidii 95% qooddatu argame, akksumas bat-CoV’n niwuukilootaayidii hoomoolojii 96% SARS-CoV-2 wajjiin qooddatutu jira.
Whereas civets and other animals in the markets have been found to harbour viruses identical to SARS-CoV, immediate intermediate hosts for SARS-CoV-2 have not been identified.
Xirinyii fi bineensonni kan biroon gabaa irra jiran bakka mijataa vaayirasii hedduun kan akka SARS-CoV fakkaatan hedduutu keessatti argama. Kallattiidhaa baattuun SARS-CoV-2 addaan hin baafamiin jira.
Pangolin beta-CoVs strikingly homologous to SARS-CoV-2 have been found, indicating that pangolins might serve as one of intermediate hosts or pangolin beta-CoVs could contribute gene fragments to the final version of SARS-CoV-2.
Paangooliinii beta-CoVsfirooma adda ta’een gara SARS-CoV-2tti argame, paangoolinootni akka baattoo giddugaleessaa tokkootti tajaajiluu ykn paangooliinii beta-CoVs gara uumamsa xumuraa SARS-CoV-2 faffaca’iinsa jiinii uumuu danda’u.
Although questions remain, there is no evidence that SARS-CoV-2 is man-made either deliberately or accidentally.
Gaaffiiwwan kan jiran yoo ta’ellee, ragaan SARS-CoV-2 itti yaadamees ta’u dingataan namaan akka uumame ibsu hin jiru.
CoVs have returned to the limelight due to the recent outbreak of SARS-CoV-2.
CoVs’n dhukkuba battalaa SARS-CoV-2 irraa kan ka’e gara fuulleffannoo harkisuutti deebi’eera.
The study of CoVs in bats and other animals has drastically changed our perception of the importance of zoonotic origins and animal reservoirs of HCoVs in human transmission.
Qo’annoon CoVs simbiroota halkanii fi bineensota biroo irratti godhamu miira barbaachisummaa madda zoonootikii fi golga bineensa HCoVs namatti daddarbuu miira keenya jijjiiree jira.
Pervasive evidence has shown that SARS-CoV, MERS-CoV and SARS-CoV-2 have a bat origin and are transmitted to humans via intermediate hosts.
Ragaan gadi fagoon akka agarsiisetti SARS-CoV, MERS-CoV fi SARS-CoV-2 bu’uura simbiroota halkanii qabu, akkasumas karaa mandhee yerootiin gara namootatti daddarbu.
Given that SARS-CoV infection originates from the contact between humans and civets in the markets, closing wet markets and killing civets therein could have effectively ended the SARS epidemic.
Dhibeen SARS-CoV gabaa keessatti waltuttuquu dhala namaa fi bineensa ‘civet’ jedhamuu irraa madduudhaan walqabatee gabaa cufanii bineensicha ajjeesuun tatamsa’ina SARS ni dhaaba.
By the same reasoning, pangolins should be removed from wet markets to prevent zoonotic transmission, in view of the discovery of multiple lineages of pangolin beta-CoVs closely related to SARS-CoV-2.
Sababeessa qal fakkaataan, paangoliiniin sababa ittisa daddarbiinsa dhibee bineeldota irraa gara namaaf gabaa keessaa baafamuu qaba, argamsa sanyii paangoliinii yeroo ilaallu beta-CoVs’n SARS-CoV-2 waliin walitti siqeenya qaba.
However, whether and how SARS-CoV-2 is transmitted to humans through pangolins and other mammals remain to be clarified in future investigations.
Yoo ta’eyyuu, haalli tatamsa’iinsa SARS-CoV-2 kara paangooliinii fi hoosistoota kan biroo gara namootaatti daddarbu ammas gara fuulduraatti qorannoon qulqullaa’uu qaba.
On the other hand, MERS-CoV has existed in dromedary camels for a long time.
Gama biroon immoo, MERS-CoV vaayirasiin jedhamu kun yeroo dheeraaf Gaalota Eshi’aa dhihaa fi Africaa kaabaa keessa jiraataa tureera.
These camels serve as an important tool for transportation as well as a main source of meat, milk, leather and wool products for the local people.
Gaalli kun meeshaa imalaa murteessaatti tajaajila, akkasumas akka madda foonii, aannanii, oomisha gogaa fi oomisha uffataatti tajaajila.
They are widely distributed across the Middle East and Africa.
Bal’inaan gama baha giddugaleessaa fi afrikaatti babal’ataniiru.
It is therefore impossible to sacrifice all camels for the control of MERS, as what was done in wild animal markets in China to prevent the spreading of SARS-CoV and SARS-CoV-2.
Sababa kanaaf, baballachuu SARS-CoV fi SARS-CoV-2 ittisuuf akka bineeldota bosonaarratti chaayinaa keessatti godhame to’annoo MERSf gaalota hunda aarsaa gochuun hin danda’amu.
To stop the recurrent outbreaks of MERS, a comprehensive approach should be taken to develop effective vaccines against MERS-CoV for camels, in combination with other infection control measures.
Weerara MERS yeroo ammaa kana dhaabuuf, tooftaalee too’annaa dhukkubootaa biroo wajjiin walitti dabaluun talaalliin amansiisaa ta’e kan MERS-CoV ittisu gaalaaf qophaa’uu qaba.
As we are not able to eliminate these viruses, new genotypes might emerge to cause outbreaks.
Vaayirasii kana guutumatti dhabamsiisuun waan hin danda’amneef jiinootaayippiin haarofni weerara fidu mul’achuu danda’a.
A variety of zoonotic CoVs are circulating in the wild.
Zoonootik CoVs garaagaraatu bosona keessa marmaaraa jira.
Particularly, bat CoVs with zoonotic potential are so diverse.
Muraasa, simbira halkanii irraa kan dhufu CoVs fi bineeldota irraa gara namaatti kan darbu garaa garummaa qaba.
There are plenty of opportunities that these zoonotic CoVs evolve and recombine, resulting in the emergence of new CoVs that are more transmissible and/or deadly in humans in future.
Carraawwan CoVs ittiin dagaaganii fi walitti makaman hedduutu jira, mul’achuu CoVs haarawaa baay’ee daddarboo ta’anii fi ajjeesanii hordofsiisaa jira.
The culture of eating wild animals in some places of China should be abandoned to reduce unnecessary contact between humans and animals.
Aadaan bineensota bosonaa nyaachuu Chaayinaa iddoo tokko tokkotti mul’atu waltuttuqqaa namaa fi bineensota gidduu jiru hir’isuuf balaaleffatamuu qaba.
With the ordeals of SARS, MERS and COVID-19, a better preparedness and response plan should be in place.
Rakkina SARS, MERS fi COVID-19, irraakan ka’e qophiifi deebiin iddootti qophaa’uu ta’a.
In fact, many viruses have existed in the planet for a very long time.
Dhugaamatti, vaayirasootni baay’een plaanetiirra yeoo dheeraaf turaniiru.
They stay in their own natural reservoirs until there is a chance for spillover.
Hamma carraan bahaa argamutti hammattuuwwan uumamaa isaanii keessa turu.
Although bats have many features that favours the spreading of viruses, the chance for humans to be in contact with bats and other wildlife species can be minimized if people are educated to stay away from them.
Simbirroonni halkanii mallattoowwan vaayirasii tamsaasuu ishee agarsiisan hedduu qabaattus karaan itti dhalli namaa simbiroota halkanii fi bineensota bosonaa biroo wajjiin tuttuqqaan qaba hir’achuu danda’u haala kamiin namoonni haala itti isaan irraa fagaatan irratti yoo barataniidha.
Continuous surveillance in mammals is necessary for better understanding of the ecology of CoVs and their natural hosts, which will prove useful in preventing animal-to-human transmission and future outbreaks.
Bineensa harma hoosisoo ta’an itti fufiinsaan hordofuun naannawa golga uumamaa CoVs baruuf fayyada, kunis gara fuulduraatti tatamsa’ina dhibee bineensaa fi nama gidduutti gara fuulduraa uumamuu danda’u beekuu fi too’achuuf fayyada.
To conclude, the most effective way to prevent viral zoonosis is for humans to stay away from the ecological niches of the natural reservoirs of the zoonotic viruses.
Guduunfuudhaaf, karaan bu’a qabeessi babal’achuu vaayirasii ittiin ttifnu namootaaf- bakka biqiloota vaayirasii huboo ta’an qaburraa fagaachuudha.
Several pieces in the puzzle of the zoonotic origin of SARS-CoV-2 are still missing.
Sanyiiwwan SARS-CoV-2 hedduun hanga ammaatti badaa jiru.
First, if bats transmit an ancestral virus of SARS-CoV-2 to pangolins, it will be of interest to see under what circumstances bats and pangolins could share the same ecological niche.
Jalqaba, yoo simbirri halkanii vaayirasii SARS-CoV-2 paangoliiniitti dabarsan, haala akkamii keessatti simbirri halkanii fi paangoliiniin bakka jireenyaa tokko qooddachuu isaanii arguun nama fayyada.
Second, if bats play a more direct role in human transmission, how humans get into contact with bats should be determined.
Lammaffaa irratti, gara namaatti dabarsuuf yoo simbira halkaniitu ga’ee guddaa qaba ta’eef, akkamittiin namoonni simbira halkanii wajjin wal-tuttuqu kan jedhu yaadamuu qaba.
Third, if a third mammal acts as the true intermediate host, how it interacts with the different species including humans, bats and pangolins has to be clarified.
Sadaffaa, yoo bineensi hoosisaan akka mandhee giddugaleessa dhugaatti tajaajila ta’e, nama dabalatee sanyiiwwan biroo wajjiin akkamitti akka walqunnamu, simbirroonni halkanii yookaan Paangoliiniin adda bahuu qabu.
Finally, since many mammals including domestic animals might be susceptible to SARS-CoV-2, both surveillance and experimental infection should be conducted.
Walumaagalattu, erga hoosiftoonni beeyiladootas dabalatee SARS-CoV-2 saaxilamoo ta’anii too’annoo fi qorannoon dhukkubichaa gaggeeffamuu qaba.
Should it be a bat, a pangolin or another mammal, it is expected that SARS-CoV-2 or its parental viruses that are almost identical will be identified in its natural hosts in future.
Simbira halkanii ta’uu qaba, paangoliinii ykn hoosiftoota biroo, SARS-CoV-2 ykn vaayirasiiwwan maatiiwwan warra adda ba’anii wajjin baattoowwan uumamaa fuulduraa ta’uusaatu eegama.
Continued investigations in this area will elucidate the evolutionary pathway of SARS-CoV-2 in animals, with important implications in the prevention and control of COVID-19 in humans.
Qorannoon naannoo kanatti itti fufe karaa daddarbiinsa SARS-CoV-2 bineensota keessatti, ittisaa fi to’annoo COVID-19 nama keessatti qabu gabaasa barbaachisaan ni ibsa.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
Tilmaama Duraa Tatamsa’ina Haalota Fayyaa Biroo Dhukkubsattoota Dhukkuba Vaayirasii Koroonaa 2019 Qabanii—Yuunaayitid Isteetsi, Gurraandhala 12—Bitootessa 28, 2020
On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic.
Bitootessa 11, 2020, Dhaabbatni Fayyaa Addunyaa Dhukkubi Vaayirasii Koroonaa 2019 (COVID-19) weerara dhibee daddarbaa ta’uu isaa labse.
As of March 28, 2020, a total of 571,678 confirmed COVID-19 cases and 26,494 deaths have been reported worldwide.
Bitootessa 28, 2020 asitti, lakkoofsa waliigalaa namoota COVID-19 dhaan qabamuun isaanii mirkanaa’e 571, 678 fi kan du’an 26,494 tu addunyaa guutummaatti gabaafamee jira.
Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions.
Gabaasawwan Chaayinaa fi Xaaliyaanii irraa argaman sababoonni dhukkuba ammaataadhaaf nama saaxilan dullumaa fi rakkoolee fayyaa dhokatoo keessaa yoo xinnaate tokko jiraachuudha yaada jedhu dhiyeessu .
U.S. older adults, including those aged ≥65 years and particularly those aged ≥85 years, also appear to be at higher risk for severe COVID-19–associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.
Ga’eessotni buleeyyiin U.S, warren umuriin isaanii ≥65 fi keessattuu warri waggaa ≥85 ta’anis, dhibee COVID-19 mudateen warra sadarkaa olaanaan hubamuu malaniidha; haa ta’u malee, haalli odeeffannoo qindataa U.S. keessaa akka ibsutti dhukkubsattootni COVI-19 ammallee hin gabaafamne.
As of March 28, 2020, U.S. states and territories have reported 122,653 U.S. COVID-19 cases to CDC, including 7,162 (5.8%) for whom data on underlying health conditions and other known risk factors for severe outcomes from respiratory infections were reported.
Bitootessa 28, 2020 asitti, mootummaawwan naannolee Yuunaayitid Isteetsii fi biyyoonni isii jala jiran namoota 7,162 (5.8%), kanneen ragaan rakkoolee fayyaa biroo irrattii fi fidumsa hamaadhaaf sababoota balaa geessisan beekamoo biroo dhukkuboota hafuuraan darbanii irraa ka’an gabaafameef dabalatee, namoonni COVID-19 qabaman 122,653 jiraachuu isaanii Giddugala To’annaa Dhibee (CDC)tti gabaasaniiru.
Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.
Namoota 7,162 keessaa, dhukkubsattoonni 2,692 (37.6%) rakkoo fayyaa biraa yookaan sababa balaa tokko yookaan isaa ol qabu, 4,470 (62.4%) immoo haalota kanniin tokko illee akka hinqabne gabaafame.
The percentage of COVID-19 patients with at least one underlying health condition or risk factor was higher among those requiring intensive care unit (ICU) admission (358 of 457, 78%) and those requiring hospitalization without ICU admission (732 of 1,037, 71%) than that among those who were not hospitalized (1,388 of 5,143, 27%).
Dhibbeentaan dhukkubsattoota COVID-19 namoota wal’aansaaf hospitaala hinseenin (5,143 keessaa 1,388, 27%) caalaatti kanneen rakkoo fayyaa biraa yookaan sababa balaa yoo xiqqaate tokko qabaatanii kutaa kunuunsa fayyaa cimaa (ICU) seenan (457 keessaa 358, 78%) fi kanneen wal’aansa mana yaalaa barbaadan garuu immoo kutaa kunuunsa fayyaa cimaa hin barbaadne (1,037 keessaa 732, 71%) gidduutti ol ka’aadha.
The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.
Warreen irra jireessaan gabaafaman haalota dhibee sukkaaraa, dhibee sombaa rakkisaa fi dibeewwan onnee waliin wal qabatan turan.
These preliminary findings suggest that in the United States, persons with underlying health conditions or other recognized risk factors for severe outcomes from respiratory infections appear to be at a higher risk for severe disease from COVID-19 than are persons without these conditions.
Argannoowwan jalqabaa kunniin akka yaada dhiyeessanitti Yuunaayitid Isteetsi keessatti, namoonni rakkoolee fayyaa biroo qaban yookaan sababoota balaa hubataman biroo dhiibbaa dhibee ujummoo qilleensaa badduu baasan qaban namoota haalota kanniin hinqabne caalaa COVID-19 irraa dhukkubi cimaan isaan qabuu danda’a.
Data from laboratory-confirmed COVID-19 cases reported to CDC from 50 states, four U.S. territories and affiliated islands, the District of Columbia, and New York City with February 12–March 28, 2020 onset dates were analyzed.
Ragaan dhukkubsattoota COVID-19 qorannoo laabiraatooriitiin mirkaneeffame irraa, kanneen mootummoota 50, kutaawwan bulchiinsaa afur U.S. keessaa fi biyyoota bishaan gidduu hidhata U.S. qaban, Kutaa Biyyaa Kolombiyaa fi Magaalaa Niiwu Yoorki irraa Giddugala To’annaa Dhibee (CDC) tti gabaafaman, kanneen guyyoonni jalqabbii isaanii Gurraandhala 12 –Bitootessa 28, 2020 ta’e qaacceffamanii jiru.
Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded.
Namoota Wuhaan, Chaayinaa irraa gara Yuunaayitid Isteetsitti deebi’anii fi hojjettoota doonii guddaa “Daayaamandi Piriinsas” keessa dhukkubsattooti jiran keessaa hambifaman.
For cases with missing onset dates, date of onset was estimated by subtracting 4 days (median interval from symptom onset to specimen collection date among cases with known dates in these data) from the earliest specimen collection.
Dhibeewwan jalqabni guyyaa hubaatii isaanio hin beekamneef, fakkeenyota dursanii qindatan irraa guyyaa jalqabbii guyyoota4 hi’isuun (tuuta giddu galeessaa qindeeffama odeeffannoo jalqabbii mallattoo gara guyyaa dhibichib itti beekamee)
Public health departments reported cases to CDC using a standardized case report form that captures information (yes, no, or unknown) on the following conditions and potential risk factors: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental, or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease.
Muummeewwan fayyaa uummataa namoota qabaman unkaa gabaasaa beekamaa namoota qabamanii, isa odeeffannoo (eeyyee, lakkii, yookaan hinbeekamne) haalota armaan gadiifi sababoota balaa ta’uu danda’anii qabachuu danda’u fayyadamuudhaan gara Giddugala To’annaa Dhibee (CDC) tti gabaasan. Odeeffannowwaniifi sababoonni balaa ta’uu malanis dhukkuba sombaa yeroo dheeraaf turu (asmii, dhibee nama ukkaamsu kan namarraa hindeemnee [COPD] fi emfiiseemaa); dhukkuba shukkaaraa; dhukkuba onnee; haala dandeettii dhukkuba ittisuu namaarra darbu; nerviin toora gadhiisuu, ‘niyuuroodivelooppimentaalii’ yookaan dandeettiin yaaduu namaa miidhamuu; ulfa ta’uu; tamboo xuuxaa jiraachuu/dhiisuu; kanaan dura tamboo xuuxaa turuu/xuuxuu dhiisuu; yookaan dhukkuba yeroo dheeraaf namarra turefaadha.
Data reported to CDC are preliminary and can be updated by health departments over time; critical data elements might be missing at the time of initial report; thus, this analysis is descriptive, and no statistical comparisons could be made.
Daataan CDC’tti dabaafame odeeffannoo jalqabaan dhaabbattoota fayyaan yeroo dabalataatti haara’uu danda’a, sa’atii gabaasa duraatti gosootni xiinxala daataa dhabamuu malu; haala kanaan xiinxalli kun hubachiisaadha, walbira qabiinsi lakkoofsotaa dhufuu hin danda’u.
The percentages of patients of all ages with underlying health conditions who were not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission were calculated.
Dhibbantaan haala dhukkubsattoota umurii hundaa jela jiranii kanneen gara hospitaalaatti hin geeffamnee, ayyama ICU malee hospitaala geeffamanii fi ayyama ICU’tiin hospitaala geeffamanii herregameera.
Percentages of hospitalizations with and without ICU admission were estimated for persons aged ≥19 years with and without underlying health conditions.
Dhibbeentaan namoota hospitaalatti yaalamaa jirankeessaa ayyama ICU argatanii warreen umuriin isaanii ≥19 ta’eef haala fayyaa salphaatti yaalamuu danda’uu fi hin dandeenyeef timaamame.
This part of the analysis was limited to persons aged ≥19 years because of the small sample size of cases in children with reported underlying health conditions (N = 32).
Xiinxalli qaama kanaa namoota umuriin isaanii waggoota ≥19 ta’eef daangeffamaadha. Sababni isaa, iddattoo xiqqoon xibeewwanii daa’imoota rakkoo fayyaa qabanii gabaafame (N=32)’dhna.
To account for missing data among these preliminary reports, ranges were estimated with a lower bound including cases with both known and unknown status for hospitalization with and without ICU admission as the denominator and an upper bound using only cases with known outcome status as the denominator.
Gabaasawwan jalqabaa kanniin keessaa ragaa hir’ate guutuuf, daangaa isa gajjallaa irraa ka’uudhaan hangi wal irraa fageenyaa tilmaame. Daangaan inni gajjallaa namoota haalli mana yaalaa seenuu isaanii beekamee fi hin beekamne, akka isa jala ooluu fi daangaa irra keessaatti kutaa kunuunsa cimaa seenuufi dhiisuu, haala bu’aa beekamaa warra qaban qofa akka isa jala ooluutti fayyadamuudhaan dabalatee jechuudha.
Because of small sample size and missing data on underlying health conditions among COVID-19 patients who died, case-fatality rates for persons with and without underlying conditions were not estimated.
Sababa naannawaa danaa xiqqoo haaloota ka’umsa fayyaa fi dhukkubsattoota COVID-19n du’an irratti odeeffannoo qindataan waan dhibeef, hammamtaan du’uu namootaa warra haalicha jela jiraniifis ta’e hin jirreef hammaataa ta’uu mala.
As of March 28, 2020, a total of 122,653 laboratory-confirmed COVID-19 cases (Figure) and 2,112 deaths were reported to CDC.
Bitootessa 28, 2020 asitti namoota COVID-19 qabamuu isaanii laabiraatooriidhaan mirkanaa’e 122,653 (Fakkii) fi kan du’an 2,112 tu Giddugala To’annaa Dhibee (CDC) tti gabaafame.
Case report forms were submitted to CDC for 74,439 (60.7%) cases.
Dhukkubsattoota 74,439 (60.7%) f uunkaan gabaasa namoota qabamanii Giddugla To’annaa Dhibee (CDC)tti galfameera.
Data on presence or absence of underlying health conditions and other recognized risk factors for severe outcomes from respiratory infections (i.e., smoking and pregnancy) were available for 7,162 (5.8%) patients (Table 1).
Daataa dhibee baramaa qabaachuu ykn dhabuu fi balaa gurguddaa sirna hargansuu irratti fidu (jechuun xuuxuu fi ulfa ta’uu)’n dhukkubsattoota 7,162 (5.8%)’f argamuu danda’a (gabatee 1).
Approximately one third of these patients (2,692, 37.6%), had at least one underlying condition or risk factor.
Tilmaamaan dhukkubsattoota kanniin harka sadii keessaa harki tokko (2,692, 37.6%), dhukkuboota biroo yookaan sababoota balaa keessaa yoo xiqqaate tokko qabu turan.
Diabetes mellitus (784, 10.9%), chronic lung disease (656, 9.2%), and cardiovascular disease (647, 9.0%) were the most frequently reported conditions among all cases.
Dhukkubsattoota hunda keessatti, dhukkubi shukkaaraa (784, 10.9%), dhukkubi sombaa hamaan (656, 9.2%), akkasumas dhukkubi onneetiifi hidda dhiigaa (647,9.0%) haalota hunda caalaa kanneen irra deddeebiidhaan gabaafaman turan.
Among 457 ICU admissions and 1,037 non-ICU hospitalizations, 358 (78%) and 732 (71%), respectively occurred among persons with one or more reported underlying health condition.
Dhukkubsattoota 457 yaalii kutaa ariifachiisaa (ICU) seenanii fi dhukkubsattoota kutaa yalii ariifachiisaa hin seeenne 1,037 hospitaala ciisan, 358(78%) fi 732 (71%) kanneen keessaa waa’een dhibee isaanii kan beeksifame tokkoo fi isaa oli.
In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition.
Faallaa kanaa, dhukkubsattoota COVID-19 5,143 keessaa 1,388 (27%), kanneen mana yaalaa hin seenin yoo xiqqaate dhibee fayyaa biraa tokko qabaachuun isaanii gabaafamee ture.
Among patients aged ≥19 years, the percentage of non-ICU hospitalizations was higher among those with underlying health conditions (27.3%–29.8%) than among those without underlying health conditions (7.2%–7.8%); the percentage of cases that resulted in an ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than those without these conditions (2.2%–2.4%) (Table 2).
Dhukkubsattoota umuriin isaanii ≥19 keessaa, dhibbeentaan namoota kunuunsa fayyaa cimaadhaaf (ICU) mana yaalaa seenanii kanneen rakkoolee fayyaa biroo qabanii (27.3%–29.8%) kanneen rakkoolee fayyaa biroo hinqabne (7.2%–7.8%) caalaa ol ka’aa ture; dhibbeentaan dhukkubsattootaa akka isaan kutaa kunuunsa fayyaa cimaa seenan isaan taasise kan warra rakkoolee fayyaa biroo qabanii (13.3%–14.5%) kan warra rakkoolee fayyaa biroo hinqabnee (2.2%–2.4%) olidha (Gabatee 2).
Small numbers of COVID-19 patients aged &lt; 19 years were reported to be hospitalized (48) or admitted to an ICU (eight).
Dhukkubsattoonni COVID-19 umurii isaanii 19 muraasni mana yaalaa seenuun isaanii (48) gabaafamee ture yookaan kutaa kunuunsa cimaa seenanii turan (saddeet).
In contrast, 335 patients aged &lt; 19 years were not hospitalized and 1,342 had missing data on hospitalization.
Faallaa kanaa ammoo, dhukkubsattoonni 335 umuriin isaanii &It fi 19 hospitaala hin deemne, akkasumas 1,342 ammoo mana yaalaa seenuurratti ragaan isaanii badee jira.
Among all COVID-19 patients with complete information on underlying conditions or risk factors, 184 deaths occurred (all among patients aged ≥19 years); 173 deaths (94%) were reported among patients with at least one underlying condition.
Dhukkubsattoota COVID-19 warra dhukkuboota biroo yookaan sababoota balaaf saaxilamuu guutuu qaban hunda keessaa, namoota 184 tu du’e (hundi isaanii umuriin isaanii 19 fi isaa olidha); warra dhukkuba biraa yoo xiqqaate tokko qaban keessaaa immoo 173 (94%) du’uutu gabaafame.
Among 122,653 U.S. COVID-19 cases reported to CDC as of March 28, 2020, 7,162 (5.8%) patients had data available pertaining to underlying health conditions or potential risk factors; among these patients, higher percentages of patients with underlying conditions were admitted to the hospital and to an ICU than patients without reported underlying conditions.
Namoota Yuunaayitid Isteetsi keessatti COVID-19 dhaan qabamuun Giddugala To’annaa Dhibee (CDC)tti gabaafame 122,653 keessaa Bitootessa 28, 2020 irraa eegalee dhukkubsattoonni 7,162 (5.8%) rakkoolee fayyaa biroo yookaan sababoota balaa mudachuu malanii qabaachuu isaanii ragaa agarsiisu qabu; dhukkubsattoota kanniin keessaa kanneen rakkoo fayyaa biraa qaban dhibbeentaa guddaan isaanii dhukkubsattoota dhukkuboota biroo qabaachuun isaanii hin gabaafamne caalaa mana yaalaa yookaan bakkee kunuunsa fayyaa cimaa (ICU) seenanii turan.
These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including, but not limited to, diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking, might be at higher risk for severe disease or death from COVID-19.
Bu’aawwan kunniin argannoowwan biyya Chaayinaa fi Xaaliyaanii waliin walsimu. Akka bu’aawwan kunniin agarsiisanitti dhukkubsattoonni rakkoolee fayyaa biroo fi sababoota balaaf saaxilan, kanneen akka dhibee shukkaaraa, dhiibbaa dhiigaa, Dhibee Nama Ukkaamsu Kan Namarraa Hindeemnee (COPD), dhukkuba onnee, dhukkuba sammuufi hidda isaa, dhukkuba kalee qabaniifi tamboo xuuxan dabalatee, garuu isaan kana qofaan utuu hin daangeffamin, dhukkuba hamaadhaan qabamuudhaaf yookaan COVID-19 dhaan du’uudhaaf carraan isaanii guddaadha.
This analysis was limited by small numbers and missing data because of the burden placed on reporting health departments with rapidly rising case counts, and these findings might change as additional data become available.
Sababa dirqami muummeewwan lakkoofsa namoota baay’inaan qabamaa jiranii gabaasuun itti kennamee jiruuf, qaaccessi kun lakkoofsa xiqqoofi ragaa hir’uu irraa kan ka’e daangeffamaa ture, argannoowwan kunniin immoo akka ragaan dabalataa argamaa deemeen jijijjiiramuu danda’u.
It is not yet known whether the severity or level of control of underlying health conditions affects the risk for severe disease associated with COVID-19.
Ciminni dhukkubichaa yookaan sadarkaan to’annaa dhukkuboota biroo dhukkuba hamaa COVID-19 waliin walqabate irraan dhiibbaa ga’uun isaa hanga ammaatti hin beekamne.
Many of these underlying health conditions are common in the United States: based on self-reported 2018 data, the prevalence of diagnosed diabetes among U.S. adults was 10.1%, and the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) was 10.6% in 2017.
Baay’een isaanii warri dhibee fayyaa qaban kunneen United States’ttis akkasuma, akka odeeffannoo of-gabaasuu 2018’tti faffaca’iimsi dhibee sukkaaraa U.S. keessaa 10.1% ture, akka qinddeessa umurii U.S.tti immoo faffaca’iinsi dhibee onnee hundaa (dhiibbaa dhiigaa dhibee onnee biroo hin qabne osoo hin dabalatiin) 10.6% ture 2017ti.
The age-adjusted prevalence of COPD among U.S. adults is 5.9%, and in 2018, the U.S. estimated prevalence of current asthma among persons of all ages was 7.9%.
Tatamsa’inni Dhibee Nama Ukkaamsu Kan Namarraa Hindeemnee (COPD) umuriidhaan qoqqoodamee kan ga’eessota Yuunaayitid Isteetsi keessaa 5.9% dha, 2018 keessa immoo, babal’ina asmii yeroo ammaa Yuunaayitid Isteetsiin tilmaamame kan namoota umurii hunda keessa jiranii 7.9% dha.
CDC continues to develop and update resources for persons with underlying health conditions to reduce the risk of acquiring COVID-19.
CDC’n namoota rakkina fayyaa beekamoo qabaniif akka COVID-19’n hin qabamneef qabeenyaan gargaaruu itti fufeera.
The estimated higher prevalence of these conditions among those in this early group of U.S. COVID-19 patients and the potentially higher risk for more severe disease from COVID-19 associated with the presence of underlying conditions highlight the importance of COVID-19 prevention in persons with underlying conditions.
Tatamsa’inni ol aanaan haalota kanniinii inni dhukkubsattoota COVID-19 garee jalqabaa Yuunaayitid Isteetsi kana gidduu jira jedhamee tilmaamamee fi COVID-19 balaa guddaa dhukkuba hamaa namatti fiduu danda’a jedhamee yaadame inni dhukkubi biraan jiraachuu waliin walitti hidhamee jiru, namoonni dhukkuboota biroo qaban COVID-19 ittisuun isaanii barbaachisaa akka ta’e agarsiisa.
The findings in this report are subject to at least six limitations.
Argannoowwan gabaasa kana keessaa yoo xiqqaate qoqqobbiiwwan jahaaf saaxilamoodha.
First, these data are preliminary, and the analysis was limited by missing data related to the health department reporting burden associated with rapidly rising case counts and delays in completion of information requiring medical chart review; these findings might change as additional data become available.
Jalqabarratti odeeffannoowwan qindatoon kunneen, akkasumas madaallichi odeeffannoo qindataan dhaabbata fayyaa olka’uu lakkoofsa dhibee sanii fi goolabbii gamaggamni yaala fayyaa gabatee barbaachisuu waliin wal qabatu dhibamuu isaatiin daangeffame; firiin yaalii kunneenii odeeffannoo qindataan dabalataa akka argamuu danda’u jijjiiruu malu.
Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC.
Odeeffannoon haalichaas dhibeewwan CDCtti gabaafaman 122,653 keessaa 7,162(5.8%) qofaaf argamuu danda’a ture.
It cannot be assumed that those with missing information are similar to those with data on either hospitalizations or underlying health conditions.
Kanneen odeeffannoo hir’uu qaban, kanneen ragaa mana yaalaa seenuu irratti yookaan dhibeewwan biroo qaban waliin walfakkaatu jedhanii tilmaamuun hin danda’amu.
Second, these data are subject to bias in outcome ascertainment because of short follow-up time.
Lammaffaa, ragaaleen kunniin sababa gabaabina yeroo hordoffii irraa kan ka’e mirkaneessa bu’aa keessatti loogiidhaaf saaxilamoodha.
Some outcomes might be underestimated, and long-term outcomes cannot be assessed in this analysis.
Firiiwwan muraasi haga tilmaamameen gadi ta’uu malu, akkasumas xiinxala kana keessatti firiin yeroo dheeraa timaamamuu hin danda’u.
Third, because of the limited availability of testing in many jurisdictions during this period, this analysis is likely biased toward more severe cases, and findings might change as testing becomes more widespread.
Sadaffaa, yeroo ammaa kanatti bakkeewwan hedduu keessatti sababa qorannoon muraasa ta’eef, qaaccessi kun harka caaluwarra dhukkuba daran hamaa ta’e qaban irratti xiyyeeffata, argannoon isaa ammoo qorannoon akka babal’ateen jijijjiiramuu danda’a.
Fourth, because of the descriptive nature of these data, attack rates among persons with and without underlying health conditions could not be compared, and thus the risk difference of severe disease with COVID-19 between these groups could not be estimated.
Arfaffaa, sababa amala ibsa ragaalee kanniiniitiif hammi haleellaa namoota rakkoolee fayyaa biroo qabanii fi hinqabne gidduu jiru waliin madaalamuu hin dandeenye; kanaaf, garaagarummaan balaa dhukkuba hamaa COVID-19 wajjinii kan gareewwan kanniin gidduu jiru tilmaamamuu hin dandeenye.
Fifth, no conclusions could be drawn about underlying conditions that were not included in the case report form or about different conditions that were reported in a single, umbrella category.
Shanaffaa, waa’ee rakkoolee fayyaa biroo, kanneen uunkaa gabaasaa keessatti hin hammatamin yookaan waa’ee haalota garaagaraa kanneen akka garee tokkicha wantoota hedduu of keessatti hammatuutti gabaafaman ilaalchisee yaada waliigalaarra ga’uun hin danda’amu.
For example, asthma and COPD were included in a chronic lung disease category.
Fakkeenyaaf, asmii fi COPD akaakuu dhibee sombaa rakkisaa keessatti hammataman.
Finally, for some underlying health conditions and risk factors, including neurologic disorders, chronic liver disease, being a current smoker, and pregnancy, few severe outcomes were reported; therefore, conclusions cannot be drawn about the risk for severe COVID-19 among persons in these groups.
Dhumarratti, rakkoowwan fayyaa dabalataa tokko tokkoo fi wantoota balaa fidaniif, toora gadhiisuu narvii, dhibee tiruu yeroo dheeraaf turu, yeroo ammaa tamboo xuuxaa jiraachuu, fi ulfa dabalatee fidumsa hamaa muraasa qofatu gabaafame; waan kana ta’eef, namoota gareewwan kanniin keessa jiraniif waa’ee balaa hamaa COVID-19 ilaalchisee yaada waliigalaa irra ga’uun hin danda’amu.
Persons in the United States with underlying health conditions appear to be at higher risk for more severe COVID-19, consistent with findings from other countries.
Namoonni Yuunaayitid Isteetsi keessaa kanneen rakkoolee fayyaa biroo qaban carraan dhibee COVID-19 hamaa ta’eef saaxilamuu isaanii guddaa fakkaata, kun immoo argannoowwan biyyoota biroo waliin walirra bu’eera.
Persons with underlying health conditions who have symptoms of COVID-19, including fever, cough, or shortness of breath, should immediately contact their health care provider.
Ho’ina qaamaa, qufaa, ciccituu hafuuraa dabalatee namootni haala fayyaasaanii keessatti mallattoo COVID-19 qabaachaa jiran, ogeessa fayyaa isaanii ariitiidhaan quunnamuu qabu.
These persons should take steps to protect themselves from COVID-19, through washing their hands; cleaning and disinfecting high-touch surfaces; and social distancing, including staying at home, avoiding crowds, gatherings, and travel, and avoiding contact with persons who are ill.
Namoonni kun COVID-19 irraa of eeguuf tarkaanfii mataa isaanii fudhachuu qabu; harkasaanii dhiqachuu,qulqulleessituu (sanitizer) fayyadan=muu, iddoo namootaa irraa of eeguu, mana turuu, iddoo namni itti baay’atu deemuu dhiisuu fi namoota dhukkubsatan waliin tuttuqqaa dhiisuu.
Maintaining at least a 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms are recommended for those with underlying health conditions.
Namooti dhibee fayyaa biroo qaban yoo xiqqaate dhiyeessii qorichaa guyyaa 30, dhiyeessii nyaataa fi wantoota barbaachisoo biroon torbanitti aal 2 akka argatan taasisuunii fimallattoolee COVID-19 beekuun ni gorfama.
All persons should take steps to protect themselves from COVID-19 and to protect others.
Namoonni hundinuu COVID-19 irraa ofii isaanii fi warren biros eeguuf tarkanfiwwan fudhachu qabu.
All persons who are ill should stay home, except to get medical care; should not go to work; and should stay away from others.
Yoo kunuunsa fayyaa isaan barbaachiseen alatti namoonni dhukkubsatan hundi mana keessa turuu qabu, hojii deemuu hinqaban, warra kaan irraas fagaachuu qabu.
This is especially important for those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19.
Kun keessumaa warren namoota waliin haaluma jiru keessatti hojjetaniif baay’ee murteessaadha. Gama biroon warra COVID-19’n balaa guddaa irraan ga’uu danda’u.
Community mitigation strategies, which aim to slow the spread of COVID-19, are important to protect all persons from COVID-19, especially persons with underlying health conditions and other persons at risk for severe COVID-19–associated disease (https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf).
Tarsiimoowwan hawaasarraa salphisuu, kanneen tatamsa’ina COVID-19 xiqqeessuu kaayyeeffatan, namoota hunda COVID-19 irraa eeguuf barbaachisoodha, keessumaa immoo namoota dhukkuboota biroo qabanii fi namoota biroo kanneen dhukkuba hamaa COVID-19 waliin walqabateen qabamuuf carraa guddaa qabaniif (https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf).
What is already known about this topic?
Waa’ee mataduree kanaa hanga ammaatti maaltu beekame?
Published reports from China and Italy suggest that risk factors for severe COVID-19 disease include underlying health conditions, but data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.
Gabaasonni maxxanfaman, kanneen Chaayinaafi Xaaliyaanii irraa akka yaada dhiyeessanitti dhukkuba hamaa COVID-19 tiif sababoonni balaa ta’an rakkoolee fayyaa biroo of keessatti qabatu, ragaan dhukkubsattoota COVID-19 Yuunaayitid Isteetsi keesssaa, kanneen rakkoolee fayyaa biroo ibsan, hanga ammaatti hin gabaafamne.
What is added by this report?
Gabaasa kanaan maaltu dabalame?
Based on preliminary U.S. data, persons with underlying health conditions such as diabetes mellitus, chronic lung disease, and cardiovascular disease, appear to be at higher risk for severe COVID-19–associated disease than persons without these conditions.
Ragaa Yuunaayitid Isteetsi jalqabaa irratti hundaa’uudhaan, namoonni dhukkuboota biroo kanneen akka dhibee shukkaaraa, dhukkuba sombaa yeroo dheeraa, akkasumas dhukkuba onnee qaban warra dhukkuboota dabalataa kanniin hinqabne caalaa dhukkuba cimaa COVID-19 waliin walqabateef saaxilamuudhaaf carraa guddaa qabu.
What are the implications for public health practice?
Agarsiistuun fayyaa addunyaa maalfaadha?
Strategies to protect all persons and especially those with underlying health conditions, including social distancing and handwashing, should be implemented by all communities and all persons to help slow the spread of COVID-19.
Tarsiimoon nama hundumaan, keessumaa warra rakkoo dhibee fayyaa qaban eeguu, gargar siquu fi harka dhiqachuu dabalatee, ummata hundumaa fi nama hundumaaa biratti daddarbiinsa COVID-19 ittisuuf hojiitti hiikamuu qaba.
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England
Dhufaatii Vaayirasii Koroonaa Haarawa (COVID-19): Seera Hordoffii Kooleejiin Rooyaal kan Hordoffii fi Qo’annoo Ogeessota Fayyaa Waligalaa Fayyaa Uummataa Ingilizii itti Fayyadamu Dheeressan
The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) have successfully worked together on the surveillance of influenza and other infectious diseases for over 50 years, including three previous pandemics.
Giddugalli Qo’annoo fi Hordoffii (RSC) Ogeeyyii Hojii Fayyaa Waliigalaa Kooleejii Rooyaal (RCGP) fi Fayyaan Uummataa Ingilizii (PHE) waggoota 50 oliif hordoffii infiluweenzaafi dhukkuboota daddarboo biroo irratti, weeraroota dhibeewwan daddarboo sadii kanaan duraa dabalatee, milkaa’inaan waliin hojjetanii jiru.
With the emergence of the international outbreak of the coronavirus infection (COVID-19), a UK national approach to containment has been established to test people suspected of exposure to COVID-19.
Ka’umsa jalqabbii dhukkuba koroonaa vaayirasii (COVID-19) biyyaalessaa wajjin, tooftaan to’annaa biyyaalessaa Yuunaayitid Kiingidam, namoota COVID-19 dhaaf saaxilamaniiru jedhamanii shakkaman qorachuudhaaf dhaabbate.
At the same time and separately, the RCGP RSC’s surveillance has been extended to monitor the temporal and geographical distribution of COVID-19 infection in the community as well as assess the effectiveness of the containment strategy.
Yerooma wal fakkaatuttiifi adda addatti, hordoffiin Giddugalli Qo’annoo fi Hordoffii (RSC) Ogeeyyii Hojii Fayyaa Waliigalaa Kooleejii Rooyaal (RCGP) faffaca’insa hawaasa keessaa dhukkuba COVID-19 kan yeroo fi bakkaanii to’achuuf, akkasumas bu’a-qabeessummaa tarsiimoo to’annaa gamaaggamuuf jecha dheereffamee jira.
The aims of this study are to surveil COVID-19 in both asymptomatic populations and ambulatory cases with respiratory infections, ascertain both the rate and pattern of COVID-19 spread, and assess the effectiveness of the containment policy.
Kaayyoowwan qo’annoo kanaa namoota mallattoo hin agarsiisneefi dhukkubsattoota socho’an, kanneen dhukkuba hafuuraan darbu qaban lachuu keessatti COVID-19 hordofuu, hammaafi amala tatamsa’ina COVID-19 mirkaneessuu, akkasumas bu’a qabeessummaa himaammata to’annaa gamaaggamuudha.
The RCGP RSC, a network of over 500 general practices in England, extract pseudonymized data weekly.
RCGP RSC’n Ingilaandi keessatti Neetwoorkii yaaliiwwan waliigalaa 500, odeeffannoo qindataa torbeef moggaasni ni dhiba.
This extended surveillance comprises of five components: (1) Recording in medical records of anyone suspected to have or who has been exposed to COVID-19.
Hordoffiin dheereffame kun wantoota shan of keessaa qaba: (1) Nama COVID-19 qaba jedhamee shakkamu yookaan nama dhukkubichaaf saaxilame galmee fayyaa keessatti galmeessuu.
Computerized medical records suppliers have within a week of request created new codes to support this.
Dhiyeessitoonni galmeewwan fayyaa koompiitaraan hojjetanii kan deeggaruudhaaf torban tokko gaaffiin dhiyeeffameef keessatti koodiiwwan haaraa uumani.
(2) Extension of current virological surveillance and testing people with influenza-like illness or lower respiratory tract infections (LRTI)—with the caveat that people suspected to have or who have been exposed to COVID-19 should be referred to the national containment pathway and not seen in primary care.
(2) Babal’isuun hordoffii qorannoo vaayirasii yeroo ammaa fi namoota dhukkuba akka infiluweenzaa yookaan dhukkuboota ujummoo qilleensaa isa gajjallaa (LRTI) qaban qorachuu—namoonni COVID-19 qabu jedhamanii shakkaman yookaan namoonni dhukkuba kanaaf saaxilaman gara kallattii to’annoo biyyaalessaatti qajeelfamuu qabu malee bakkee kunuunsa bu’uraa keessatti argamuu hinqaban akeekkachiisa jedhu waliin.
(3) Serology sample collection across all age groups.
(3) Funaansa samuuda qorannoo dhiigaa kan gareewwan umurii hundaa.
This will be an extra blood sample taken from people who are attending their general practice for a scheduled blood test.
Kuni naamunaa dhiigaa baayyee uummata walii galaatti qorannoodhaaf achitti dabaree isaanii eegaa jiran irraa kan fuudhameedha
The 100 general practices currently undertaking annual influenza virology surveillance will be involved in the extended virological and serological surveillance.
Ogeessonni fayyaa 100 kanneen yeroo ammaa hordoffii vaayirasii infiluweenzaa kan waggaa adeemsisaa jiran hordoffii qorannoo vaayirasiitii fi dhiigaa dheereffame keessatti ni hirmaatu.
(4) Collecting convalescent serum samples.
(4) Samuudota dhiiga nama dhukkubicha dandamatee walitti qabuu.
We have the opportunity to escalate the data extraction to twice weekly if needed.
Yoo barbaachisaa ta’e ragaalee walitti qabnu kana ol guddisnee torbanitti yeroo lama guuruuf carraa qabna.
Swabs and sera will be analyzed in PHE reference laboratories.
Samuudi huccuu cittuun dhufeefi dhiigi laabiraatooriiwwan Fayyaa Uummataa Ingilizii (PHE) kan irraa ilaalanii hojjettan keessatti qaacceffama.
General practice clinical system providers have introduced an emergency new set of clinical codes to support COVID-19 surveillance.
Hordoffii COVID-19 deeggaruuf dhiyeessitoonni tajaajila waliigalaa mala wal’aansaa koodii wal’aansaa haaraa kan yeroo atattamaa eegalaniiru.
Additionally, practices participating in current virology surveillance are now taking samples for COVID-19 surveillance from low-risk patients presenting with LRTIs.
Dabalataan, ogeessonni fayyaa hordoffii qorannoo vaayirasii yeroo ammaa keessatti hirmaachaa jiran hordoffii COVID-19 tiif dhukkubsattoota saaxilammi isaanii gad aanaa ta’e dhibamuu ujummoo qilleensaa wara gajjallaa (LRTI) isaanii dhiyeessuudhaan samuuda irraa fuudhaa jiru.
Within the first 2 weeks of setup of this surveillance, we have identified 3 cases: 1 through the new coding system, the other 2 through the extended virology sampling.
Hordoffiin kun eegalamee torban jalqabaa 2n keessatti dhukkubsattoota 3 adda baasnee jirra: 1 karaa sirna koodii gochuu isa haaraa, warri hafan 2n immoo karaa samuudessuu qorannoo vaayirasiitiin addda baafaman.
We have rapidly converted the established national RCGP RSC influenza surveillance system into one that can test the effectiveness of the COVID-19 containment policy.
Mala hordoffii infiluweenzaa Giddugalli Qo’annoo fi Hordoffii (RSC) Ogeeyyii Hojii Fayyaa Waliigalaa Kooleejii Rooyaal (RCGP) biyyoolessaa baratamee jiru atattamaan gara isa bu’a qabeessummaa imaammata to’annaa COVID-19 qorachuu danda’uutti jijjiirree jirra.
The extended surveillance has already seen the use of new codes with 3 cases reported.
Baballiinsa to’annoo gabaasa dhibee gabaafame 3 wajjin bu’aan lakkaddaa haaraa mullateera.
Rapid sharing of this protocol should enable scientific critique and shared learning.
Seerota kanniin dafanii waliif qooduun qeeqa saayinsaawaa argachuu fi beekumsa waliif qooduu nama dandeessisuu qaba.
The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) is a network of general practices (GPs) with a nationally representative population that provides pseudonymized data for weekly surveillance of infectious diseases.
Giddugalli Qo’annoo fi Hordoffii (RSC) Ogeeyyii Hojii Fayyaa Waliigalaa Kooleejii Rooyaal (RCGP) walitti hidhama hojiiwwan fayyaa waliigalaa (GPs) baayi’na sadarkaa biyyaaessaatti bakka bu’aa ta’e qabu, kan hordoffii torban torbanii dhibeewwan daddarbootiif ragaa maqaan nama ragaa kennee dhokfamedhiyeessudha.
The disease surveillance program is commissioned by Public Health England (PHE) and covers 37 infectious diseases, including influenza.
Sagantaa hordoffii dhukkubaa kana Fayyaa Uummataa Ingilizii (PHE)tu akka hojjetamuuf kenne. Sagantaan kun infiluweenzaa dabalatee dhukkuboota daddarboo 37 waliin ga’a.
The RCGP RSC and PHE have an established collaboration of over 50 years in influenza and respiratory disease surveillance and are now in their 53rd season of surveillance and analysis.
Giddugalli Qo’annoo fi Hordoffii (RSC) Ogeeyyii Hojii Fayyaa Waliigalaa Kooleejii Rooyaal (RCGP) fi Fayyaa Uummataa Ingilizii (PHE) hordoffii infiluweenzaatiifi dhukkuba ujummoo qilleensaa irratti waggoota 50 oliif gamtaa bu’urri isaa cimaa qabu, amma immoo waqtii 53 ffaa hordoffii fi qaaccessaa keessa jiru.
The RCGP RSC extracts pseudonymized data from a nationally representative sample of over 500 urban and nonurban GPs each week covering a population of over 4 million.
Giddugalli Qo’annoo fi Hordoffii (RSC) Ogeeyyii Hojii Fayyaa Waliigalaa Kooleejii Rooyaal (RCGP) ragaa maqaan abbaa ragaa dhokataa iddattoo biyyaalessa bakka bu’u, kan namoota miliyoona 4 olii, ogeessota fayyaa magaalaa fi baadiyyaa jiran 500 irraa torban torbaniin walitti qaba.
Data from these practices are reported online in a weekly return, which includes monitoring weekly rates of influenza-like illness (ILI) and other communicable and respiratory diseases in England.
Ragaaleen hojiiwwan kanniin irraa argaman torban torbaniin toora intarneetiirratti gabaafamu, kun immoo dhukkuba dhibee qufaa fakkaatu (ILI) akkasumas dhukkuboota namaa namatti darbanii fi dhukkuboota qaamolee hafuura baafannaa biroo biyya Ingilizii keessaatiin torbanitti namni meeqa akka qabame to’achuufaa dabalata.
We also produce an annual report.
Akkasumas, gabaasa waggaa ni qopheessina.